Efficacy and safety of IMC-001, anti-PD-L1 antibody, in patients with relapsed or refractory extranodal NK/T cell lymphoma, nasal type (R/R ENKTL)
- Authors
- Kim, W. S.; Jo, J-C.; Koh, Y.; Yang, D. H.; Yoon, D. H.; Kwon, J. H.; Lee, G-W.; Yoo, K. H.; Oh, J.; Lee, J. H.; Kim, H. T.
- Issue Date
- Nov-2022
- Publisher
- Oxford University Press
- Citation
- Annals of Oncology, v.38, no.9, pp S1516 - S1516
- Indexed
- SCIE
SCOPUS
- Journal Title
- Annals of Oncology
- Volume
- 38
- Number
- 9
- Start Page
- S1516
- End Page
- S1516
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/30769
- DOI
- 10.1016/j.annonc.2022.10.242
- ISSN
- 0923-7534
1569-8041
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.